The preliminary revenue for Q1 2026 is projected at $2.2 million, reflecting a 37% increase compared to Q1 2025 and an 80% increase over Q4 2025. CEO Mike DePasquale highlighted the company's strategic transition to selling only BIO-key branded solutions in the EMEA region, which is anticipated to enhance gross margins and growth prospects moving forward. The company also reported a significant increase in hardware revenue, which more than doubled in 2025, driven by increased purchases of biometric hardware solutions.
Despite a net loss of $4.6 million for 2025, the company is optimistic about its future, citing a broad base of achievements and a strong start to 2026. The company has also seen traction with foreign military and defense customers, securing follow-on orders and expanding its partnerships in various regions, including India and the Middle East. The outlook for 2026 remains positive, with expectations for solid revenue growth and improved bottom-line performance as the company continues to expand its customer base and product offerings.
